Series C - Barosense
Investment Firm
Overview
BaroSense develops minimally-invasive therapeutic weight loss procedures, devices and surgical treatments for the obese.
Announced Date
Dec 05, 2007
Funding Type
Series C
Highlights
Location
United States, North America
Social
Investor Lead
N/A
Participant Investors
6
Round Details and Background
Barosense raised $11205000 on 2007-12-05 in Series C
BaroSense develops minimally-invasive therapeutic weight loss procedures, devices and surgical treatments for the obese.
Company Funding History
4
| Announcment Date | Transaction Name | Number Of Investors | Lead Investor | Money Raised |
|---|---|---|---|---|
| Dec 05, 2007 |  Series C - Barosense | 6 | - | 11.2M |
| Dec 22, 2004 | Series B - Barosense | 4 | - | 6.2M |
| Jul 22, 2002 | Series A - Barosense | 2 | - | 6.2M |
| Aug 24, 2009 | Series D - Barosense | 8 | - | 27.0M |
Recent Activity
There is no recent news or activity for this profile.